Best Orthopedics Companies in South Korea
The 65 best Orthopedics companies in South Korea in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: CONNECTEVE.
- Orthopedics Market: Rising Burden of Orthopedic Diseases in Developed
Our analysis of 50 Orthopedics companies
$3.4b in tracked funding; 82% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Orthopedics companies in South Korea
| # | Company | Disclosed funding | Last round | Stage | Founder | Founded | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | CONNECTEVE Provider of AI-based automated robotic system for orthopedic disorders in the elderly 27Moat top 38%Innovation top 41%Funding top 41%Patents top 41% All 7 signals ▾Moattop 38% Innovationtop 41% Fundingtop 41% Patentstop 41% AItop 45% Globalbottom 36% Marketbottom 16% Moat: Editorial + unicorn rating 4/10 · IP moat: 20 patents Innovation: 20 patents (top 73% of patent-holders) · 20 filings since 2022 vs 0 in 2017-21 rank vs industry peers · Fliar Intelligence Index 27/100 | $10M | 16 mo ago | Series A | — | 2021 | — | 20 patents Robotic joint surgery systems and AI-driven osteoarthritis assessment tools | — |
| 2 | h robotics H Robotics develops, manufactures, and distributes state-of-the-art rehabilitation solutions. | $10M | 56 mo ago | Series B | — | 2018 | — | 352 patents Medical and rehabilitation robotics, autonomous transport robots, and ML-guided surgical navigation | — |
| 3 | H·ROBOTICS Developer of robotic rehabilitation systems | $10M | 56 mo ago | Series B | Chunbae Lee CEO | 2018 | — | 352 patents Medical and rehabilitation robotics: surgical tool control, gait training, autonomous transport systems. | — |
| 4 | Connext Provider of therapeutic solution for treating orphan diseases 22Funding top 36%Moat top 38%Patents top 49%Innovation bottom 45% All 8 signals ▾Fundingtop 36% Moattop 38% Patentstop 49% Innovationbottom 45% Talentbottom 45% Globalbottom 31% Marketbottom 29% Techbottom 29% Funding: Raised $9.9M across 1 rounds · 1 rounds over 1 yrs (1.0/yr) Moat: Editorial + unicorn rating 4/10 · IP moat: 9 patents rank vs industry peers · Fliar Intelligence Index 22/100 | $10M | 3 mo ago | Series C | Woo-Jong Lee CEO & Owner | 2017 | GnuboardMySQLPHP+15 | 9 patents Stabilized collagenase enzyme formulations for biomedical and industrial applications | — |
| 5 | EXOSYSTEMS Developer of a wearable medical device used for rehabilitation | $4M | 55 mo ago | Series A | Hooman Lee Founder & Co-CEO | 2016 | — | 30 patents Patents concentrated in health & consumer products | — |
| 6 | Superin Therapeutics Developer of cell-based therapeutics for spinal cord injury | $2M | 79 mo ago | Series A | Jeong Beom Kim Founder & CEO | 2017 | — | — | — |
| 7 | KSB Tugen Developer of therapeutics for treating multiple diseases | $175K | 36 mo ago | Seed | Jeong Hyo Co-CEO | 2020 | — | 29 patents Pharmaceutical racetam-based treatments for eye disorders and muscle degeneration. | — |
| 8 | innosys Provider of advanced electronic devices, circuit, and subsystems for system design and manufacturing | — | 30 mo ago | Public | Youngwoong Ko CEO | 1993 | — | 23 patents Patents concentrated in health & consumer products | — |
Top 10 Orthopedics companies in South Korea
#1
Series C · Yeongcheon si, North Gyeongsang Province · founded 2017 · 23 employees$9.9Mraised▾
Provider of therapeutic solution for treating orphan diseases. The company pipeline products are TLR and TLR5 which can be used for agonists in pathogen recognition and activation of innate immunity, pathogen-associated molecular patterns (PAMPs) used for diseases like GvHD, Mucositis, and ARS. Other products offered by the company are Collagenase enzymes derived from microorganisms that break down collagen and used for the treatment of different musculoskeletal diseases like Dupuytren’s contracture, Peyronie’s Disease, Cellulite, and Wound debridement.
- Mar 2026Series C$9.9M
#2
Series A · Seoul, Seoul · founded 2021 · 1 employees$10.5Mraised▾
Provider of AI-based automated robotic system for orthopedic disorders in the elderly. It offers artificial joint surgery robots and a musculoskeletal precision analysis system for diagnosing knee osteoarthritis.
- Feb 2025Series A$10.5M
#3
Series B · Pohang, Kyongsang-bukto · founded 2018 · 17 employees$10Mraised▾
Developer of a rehabilitation device designed to enhance the lack of rehabilitation manpower supply and to reduce the economic burden of patients. The company's device is linked to a cloud-based remote rehabilitation treatment technology where it is possible to respond quickly to the need for remote treatment, which is rapidly emerging with the recent coronavirus epidemic as well as intensive rehabilitation, enabling patients to get treatment for all four rehabilitation areas of elbows, wrists, knees, and ankles, as well as patients with neurological diseases such as musculoskeletal diseases and strokes.
#4
Series B · Pohang si, North Gyeongsang Province · founded 2018 · 11 employees$10Mraised▾
Developer of robotic rehabilitation systems. Its features include integrated telemedicine software, assist-as-needed control, treatment for various conditions related to joint, muscle, and neurological pathologies, as well as passive motion and range of motion measurement. It enables remote rehabilitation of patients in their homes and clinics.
- Oct 2021Series B$10M
#5
Series A · Seongnam-si, Gyeonggi-do · founded 2016 · 19 employees$4.5Mraised▾
Developer of a wearable medical device used for rehabilitation. The company's solution provides optimized exercise programs to patients through analyzing user rehabilitation activity data. The device helps people suffering from joint problems.
- Oct 2021Series A$3.9M
- May 2017Seed$268K
#6
Series A · Ulsan, Ulsan · founded 2017 · 4 employees$1.7Mraised▾
Developer of cell-based therapeutics for spinal cord injury. It offers a lead compound SGS101 is an implantable ECM-based natural polymer-based hydrogel to protect the wound on spinal cord.
- Nov 2019Series A$1.7M
#7
Seed · Seoul, Seoul · founded 2020 · 8 employees$175.5Kraised▾
Developer of therapeutics for treating multiple diseases. It offers a clinical multi-omics-based treatment for refractory sarcopenia, presbyopia, Duchhene muscular dystrophy, and renal failure.
- Jun 2023Seed—
- Jul 2021Seed$175.5K
#8
Public · Uijeongbu, Gyeonggi-do · founded 1993—raised▾
Provider of advanced electronic devices, circuit, and subsystems for system design and manufacturing.
#9
Series A · Seongnam-si, Gyeonggi-do · founded 2018 · 16 employees—raised▾
HaplnScience developer of drugs for anti-aging and osteoarthritis treatment. The company pipeline drug candidates are HS101, targeting musculoskeletal, for osteoarthritis, is in the pre-clinical stage, HS201 and HS301 targeting skin and hair health for treating wrinkles and aged skin and alopecia are in DDS Stage of the clinical study. The technology is based on HAPLN1, a protein that can reverse tissue degeneration by strengthening the extracellular matrix.
- Jul 2019Series A—
#10
Public · Cheonan, Hoseo · founded 1998 · 47 employees—raised▾
Oscotec is a Korean, clinical-stage, biopharma developing small molecule therapeutics for arthritis and cancer indications. They have 3 candidates in clinical trials- SKI-O-703, an SYK inhibitor for rheumatoid arthritis; SKI-O-801, an FLT3 inhibitor for Acute Myeloid Leukemia; and GNS-1480, an EGFR Inhibitor for non-small cell lung cancer.
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Orthopedics coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Medical Devices is moving in South Korea
A read on the academic research around Medical Devices — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 229 South Korea-affiliated papers.
- Korea Advanced Institute of Science and Technology28
- Seoul National University21
- Yonsei University19
- Pusan National University17
- Korea University11
- Surgical robot16
- Robot14
- Robotic surgery4
- Invasive surgery4
- Workspace4
- Surgical robot56
- Robot44
- Haptic technology12
- Robotic surgery12
- Surgical instrument12
- Biomedical engineering1→4
Where medical devices is researched across South Korea
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Who's filing medical devices patents in South Korea
South Korea medical devices patent filing is accelerating — 101,861 filings from 8,000 assignees (2016–2025), led by Samsung, UNIV Korea RES & BUS Found, Korea Advanced INST SCI & TECH; annual filings 7688→11853.
- Samsung17681
- UNIV Korea RES & BUS Found1952
- Korea Advanced INST SCI & TECH1612
- LG Electronics1599
- UNIV Yonsei IACF1292
- I SENS1154
- KT & G1005
- Medison999
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.